Literature DB >> 21744858

Fluorescent derivatives of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells.

Carmen Abate1, John R Hornick, Dirk Spitzer, William G Hawkins, Mauro Niso, Roberto Perrone, Francesco Berardi.   

Abstract

Fluorescent derivatives of σ(2) high affinity ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine 1 (PB28) were synthesized. NBD or dansyl fluorescent tags were connected through a 5- or 6-atom linker in two diverse positions of 1 structure. Good σ(2) affinities were obtained when the fluorescent tag was linked to 5-methoxytetralin nucleus replacing the methyl function. NBD-bearing compound 16 displayed high σ(2) affinity (K(i) = 10.8 nM) and optimal fluorescent properties. Its uptake in pancreatic tumor cells was evaluated by flow cytometry, showing that it partially occurs through endocytosis. In proliferating cells, the uptake was higher supporting that σ(2) receptors are markers of cell proliferation and that the higher the proliferation is, the stronger the antiproliferative effect of σ(2) agonists is. Colocalization of 16 with subcellular organelles was studied by confocal microscopy: the greatest was in endoplasmic reticulum and lysosomes. Fluorescent σ(2) ligands show their potential in clarifying the mechanisms of action of σ(2) receptors.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744858      PMCID: PMC3181126          DOI: 10.1021/jm200591t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  38 in total

Review 1.  Potential antidepressant activity of sigma ligands.

Authors:  Grazyna Skuza
Journal:  Pol J Pharmacol       Date:  2003 Nov-Dec

Review 2.  Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy.

Authors:  Véronique Megalizzi; Marie Le Mercier; Christine Decaestecker
Journal:  Med Res Rev       Date:  2010-08-04       Impact factor: 12.944

3.  Function of sigma1 receptors in Parkinson's disease.

Authors:  M Mishina; K Ishiwata; K Ishii; S Kitamura; Y Kimura; K Kawamura; K Oda; T Sasaki; O Sakayori; M Hamamoto; S Kobayashi; Y Katayama
Journal:  Acta Neurol Scand       Date:  2005-08       Impact factor: 3.209

4.  Design and evaluation of naphthol- and carbazole-containing fluorescent sigma ligands as potential probes for receptor binding studies.

Authors:  Savina Ferorelli; Carmen Abate; Nicola Antonio Colabufo; Mauro Niso; Carmela Inglese; Francesco Berardi; Roberto Perrone
Journal:  J Med Chem       Date:  2007-08-22       Impact factor: 7.446

5.  Novel analogs of the sigma receptor ligand BD1008 attenuate cocaine-induced toxicity in mice.

Authors:  Rae R Matsumoto; Deborah L Gilmore; Buddy Pouw; Wayne D Bowen; Wanda Williams; Amina Kausar; Andrew Coop
Journal:  Eur J Pharmacol       Date:  2004-05-10       Impact factor: 4.432

6.  Low density of sigma1 receptors in early Alzheimer's disease.

Authors:  Masahiro Mishina; Masashi Ohyama; Kenji Ishii; Shin Kitamura; Yuichi Kimura; Kei-ichi Oda; Kazunori Kawamura; Toru Sasaki; Shiro Kobayashi; Yasuo Katayama; Kiichi Ishiwata
Journal:  Ann Nucl Med       Date:  2008-05-23       Impact factor: 2.668

7.  Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes.

Authors:  Daniel Gebreselassie; Wayne D Bowen
Journal:  Eur J Pharmacol       Date:  2004-06-16       Impact factor: 4.432

8.  Sigma-2 receptors as a biomarker of proliferation in solid tumours.

Authors:  K T Wheeler; L M Wang; C A Wallen; S R Childers; J M Cline; P C Keng; R H Mach
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

9.  Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells.

Authors:  I Al-Nabulsi; R H Mach; L M Wang; C A Wallen; P C Keng; K Sten; S R Childers; K T Wheeler
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

10.  Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules.

Authors:  J E Schnitzer; P Oh; E Pinney; J Allard
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  8 in total

1.  Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors.

Authors:  Carmen Abate; Chiara Riganti; Maria Laura Pati; Dario Ghigo; Francesco Berardi; Timur Mavlyutov; Lian-Wang Guo; Arnold Ruoho
Journal:  Eur J Med Chem       Date:  2015-12-13       Impact factor: 6.514

Review 2.  Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands.

Authors:  John R Hornick; Dirk Spitzer; Peter Goedegebuure; Robert H Mach; William G Hawkins
Journal:  Surgery       Date:  2012-07-03       Impact factor: 3.982

Review 3.  The σ2 receptor: a novel protein for the imaging and treatment of cancer.

Authors:  Robert H Mach; Chenbo Zeng; William G Hawkins
Journal:  J Med Chem       Date:  2013-06-18       Impact factor: 7.446

4.  Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer.

Authors:  John R Hornick; Suwanna Vangveravong; Dirk Spitzer; Carmen Abate; Francesco Berardi; Peter Goedegebuure; Robert H Mach; William G Hawkins
Journal:  J Exp Clin Cancer Res       Date:  2012-05-02

5.  Preferential Mitochondrial Localization of a Goniothalamin Fluorescent Derivative.

Authors:  Ismael Raitz; Roberto Y de Souza Filho; Lorena P de Andrade; Jose R Correa; Brenno A D Neto; Ronaldo A Pilli
Journal:  ACS Omega       Date:  2017-07-20

6.  Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.

Authors:  Chia-Chi Liu; Ching-Fang Yu; Shu-Chi Wang; Hsueh-Yin Li; Chiu-Min Lin; Hsia-Han Wang; Carmen Abate; Chi-Shiun Chiang
Journal:  BMC Cancer       Date:  2019-05-20       Impact factor: 4.430

Review 7.  PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships.

Authors:  Carmen Abate; Mauro Niso; Francesca Serena Abatematteo; Marialessandra Contino; Nicola Antonio Colabufo; Francesco Berardi
Journal:  Front Pharmacol       Date:  2020-12-07       Impact factor: 5.810

Review 8.  Proceedings from the Fourth International Symposium on σ-2 Receptors: Role in Health and Disease.

Authors:  Nicholas J Izzo; Martí Colom-Cadena; Aladdin A Riad; Jinbin Xu; Meharvan Singh; Carmen Abate; Michael A Cahill; Tara L Spires-Jones; Wayne D Bowen; Robert H Mach; Susan M Catalano
Journal:  eNeuro       Date:  2020-11-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.